Definitive Contract HHSD200201793429C

Award Date 4/1/17
Potential Completion Date 9/30/22
Potential Value $13M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Plandome, NY 11030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
7
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Feinstein Institutes for Medical Research, a leading non-profit medical research organization. The $249,647.00 contract is for a study of cancer incidence among Pace University employees. The contract has a period of performance through May 15, 2025 and is a cost-type contract with no fee. The Feinstein Institutes has a strong track record of federal contract and grant awards, often collaborating...
This $21,361 firm fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to The Feinstein Institutes for Medical Research, a non-profit research organization. The contract is for examining the relationship between vitamin D and reproductive function using menstrual effluent, with a completion date of August 29, 2024. The Feinstein Institutes has a strong track record of...
This is a $68,260,751.00 definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the City of New York Fire Department for World Trade Center Health Program Clinical Center of Excellence services. The contract provides for cost-plus fixed fee healthcare services, data management, and research support related to monitoring and analyzing health impacts on September 11 survivors and responders. The contract does not have a...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Icahn School of Medicine at Mount Sinai (ISMMS) to provide World Trade Center Health Program Clinical Center of Excellence services. The contract has a total ceiling value of $129,501,824.39 and runs through September 30, 2022. The contract is not set aside for any special designation. ISMMS, a private university and non-profit organization, is providing specialized medical services and...
This is a $9,633,305.62 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Long Island Jewish Medical Center, a hospital and non-profit organization that is part of the Northwell Health system. The contract is to operate as a World Trade Center Health Program Clinical Center of Excellence through March 2017, providing limited healthcare services to responders and survivors of the 9/11 attacks, including quality assurance, care coordination, healthcare...
This is a $146,933,829.33 cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to The Research Foundation for the State University of New York, doing business as Stony Brook University. The contract is to establish and operate World Trade Center Health Program (WTCHP) Clinical Centers of Excellence (CCEs) to provide healthcare delivery services to responders and survivors of the 9/11 attacks through the WTCHP program. The contract has a base period of...
This is a $118,078,627.62 cost-plus-fixed-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the City of New York Fire Department for the World Trade Center Health Program (WTCHP) Clinical Center of Excellence. The contract has a period of performance through September 28, 2030 and does not have a set-aside designation. The contract requires the Fire Department, a local government entity, to provide healthcare services including monitoring, screening,...
The federal contract award is for the World Trade Center Health Program (WTCHP) Clinical Center of Excellence, provided by New York University (NYU) School of Medicine, a leading academic medical center and research institution. The $24,549,325.00 cost-plus-fixed-fee definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) on September 29, 2022, with a performance period through September 28, 2030. The contract is not set aside for any specific business type. The...
This is a $340,841,557.63 definitive cost-no-fee contract awarded by the Centers for Disease Control and Prevention (CDC) to the Icahn School of Medicine at Mount Sinai (ISMMS) to establish and operate a World Trade Center Health Program (WTCHP) Clinical Center of Excellence. The contract has an ultimate completion date of September 28, 2030. The original solicitation was a pre-solicitation notice from the National Institute for Occupational Safety and Health (NIOSH) to competitively procure...
This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Research Foundation for the State University of New York (RF SUNY), which is the parent organization of Stony Brook University. The contract, valued at $66,686,909.00, is for World Trade Center Health Program Clinical Center of Excellence Services. The contract is a definitive contract with a cost no fee pricing type, and has a completion date of September 30, 2022....

This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Feinstein Institutes For Medical Research, a non-profit organization located in Plandome, New York. The $13,296,353 contract, which does not have a set-aside designation, is for World Trade Center Health Program Clinical Center of Excellence Services. The contract has a completion date of September 30, 2022 and was originally awarded on April 1, 2017. The Feinstein Institutes For Medical Research is a biomedical research organization that has received over $35 million in past federal grants from agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, and Department of Defense to conduct research on topics including autoimmune disorders, sepsis, cancer, neonatal health, mental health, and cardiovascular diseases.

Generated 3/23/24, 8:42 PM